問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number70033093STR3001
NCT Number(ClinicalTrials.gov Identfier)-
Active

2023-05-01 - 2027-06-24

Phase III

Recruiting12

ICD-10G45.0

Vertebro-basilar artery syndrome

ICD-9435.0

Basilar artery syndrome

-

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/13

Investigators and Locations

Principal Investigator Lung Chan Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 孫瑜 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳彥中 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 劉嘉為 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 李孟 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 黃雯怡 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsong-Hai Lee Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Kang-Hsu Lin Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張楷杰 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張育銘

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 鍾芷萍 Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Jiann-Shing Jeng

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    250 participants

  • Global

    15000 participants